SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-037486
Filing Date
2008-06-06
Accepted
2008-06-06 17:51:07
Documents
1
Period of Report
2008-06-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd210145.html 4  
1 FORM 4 rrd210145.xml 4 3827
  Complete submission text file 0001181431-08-037486.txt   5958
Mailing Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006
Business Address 3625 132ND AVENUE SE SUITE 400 BELLEVUE WA 98006 4253730171
SCOLR Pharma, Inc. (Issuer) CIK: 0000934936 (see all company filings)

IRS No.: 911689591 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1

Mailing Address C/O SCOLR PHARMA INC 3625 - 132ND AVENUE SE SUITE 300 BELLEVUE WA 98006
Business Address 425 373 0171
TURNER STEPHEN (Reporting) CIK: 0001270084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31982 | Film No.: 08886668